Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 793
interventional 693
Observational 96
Registry 4

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug|placebo 287
Drug 214
Biological|placebo 46
Other 28
Biological 27
Device 18
Procedure 11
Dietary Supplement|placebo 10
Device|placebo 8
Biological|Drug|placebo 5
Dietary Supplement 5
Drug|Other 5
Biological|Drug 4
Biological|Other 3
Drug|Other|placebo 3
Drug|Procedure 3
Other|placebo 3
Device|Drug|placebo 2
Device|Procedure 2
Diagnostic Test 2
Behavioral|Device|placebo|Procedure 1
Biological|Procedure 1
Device|Drug 1
Diagnostic Test|Other 1
Dietary Supplement|Drug|placebo 1
Other|Procedure 1
placebo 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 187
NA 146
Canada 44
Germany 40
Korea, Republic of 23
Austria 20
United Kingdom 20
China 18
Japan 17
Spain 16
Thailand 15
Sweden 14
Italy 11
Denmark 8
France 8
Belgium 7
Taiwan 7
United States|Canada 7
Brazil 6
Netherlands 6
Poland 6
Switzerland 6
NA 4
Australia 4
Norway 4
Finland 3
India 3
Hong Kong 2
Russian Federation 2
Singapore 2
Argentina|Australia|Korea, Republic of|Russian Federation 1
Austria|Belgium|Germany|Netherlands|Spain 1
Belarus|Russian Federation 1
Belgium|Czech Republic|Germany|Poland|Slovakia 1
Belgium|Germany|Netherlands|Poland 1
Belgium|Netherlands 1
Bulgaria 1
Canada|United States|Argentina|Chile|France|Italy|Peru 1
Croatia 1
Czech Republic|Denmark|Estonia|Finland|France|Germany|Latvia|Lithuania|Poland|Slovakia|Sweden 1
Czech Republic|Germany|Poland 1
Denmark|Finland|France|Germany|Lithuania|Poland|Russian Federation|Sweden 1
Denmark|Finland|Germany|Lithuania|Norway|Poland|Slovakia|Sweden 1
Estonia|Latvia|Lithuania|Netherlands|Russian Federation|Sweden 1
Germany|Lithuania|Poland 1
Germany|Poland 1
Germany|United Kingdom 1
Hungary 1
Hungary|Poland|United Kingdom 1
Hungary|Spain 1
Malaysia 1
Mexico 1
Netherlands|United Kingdom 1
Pakistan 1
Philippines 1
Poland|Denmark|France|Latvia|Lithuania|Sweden|Switzerland 1
Spain|Sweden 1
Sweden|Ukraine 1
United States|Argentina|Chile|Finland|Italy|Mexico|Slovakia 1
United States|Australia|Canada|Estonia|Germany|Latvia|Lithuania|New Zealand|Russian Federation 1
United States|Canada|Czechia|Germany|Norway|Puerto Rico|Romania 1
United States|Canada|Czechia|Germany|Norway|Romania 1
United States|Canada|Estonia|Germany|Hungary|Russian Federation|Slovakia 1
United States|Canada|Estonia|Poland 1
United States|France 1
United States|Poland|Russian Federation|Spain 1
Vietnam 1

Sites per Study

Site_count Study_Count
1 504
2 31
3 12
4 14
5 10
6 12
7 14
8 5
9 3
10 2
11 2
12 2
13 2
14 4
15 3
16 1
17 1
18 1
19 2
20 1
22 2
23 3
24 3
25 1
26 3
28 3
29 1
30 3
31 4
32 1
33 1
34 3
35 3
36 1
37 2
38 1
39 3
40 1
41 2
42 2
43 3
44 1
45 3
49 1
53 1
56 1
59 2
60 2
63 1
65 1
66 2
71 1
74 2
80 1
121 1
125 1

Phase

Phase Study_Count
Phase 3 219
Phase 2 138
Phase 4 138
N/A 99
Phase 1 69
Phase 1/Phase 2 15
Phase 2/Phase 3 13
Early Phase 1 2

Number of Arms

Number_of_Arms Count_of_Studies
1 76
2 317
3 116
4 64
5 22
6 9
7 2
8 2
9 4
16 1
NA 80

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 21.00 6.0000 6.00000 12.0000 11.0000 15.0000 1.000 7.0000
1st Qu. 27.25 25.2500 26.00000 32.0000 42.5000 38.0000 122.000 40.2500
Median 33.50 50.0000 36.00000 48.0000 79.0000 100.0000 347.500 99.0000
Mean 33.50 109.2347 67.30435 115.7333 186.1739 193.0769 448.844 195.7464
3rd Qu. 39.75 96.0000 48.00000 81.0000 253.0000 110.0000 617.000 263.2500
Max. 46.00 2701.0000 1307.00000 800.0000 1111.0000 784.0000 2388.000 1260.0000

Trial Group Type

group_type Group_Count
Experimental 749
Placebo Comparator 399
Active Comparator 355
NA 80
Other 27
No Intervention 16
Sham Comparator 14

Intervention Model

intervention_model Study_Count
Parallel Assignment 462
Crossover Assignment 138
Single Group Assignment 80
Factorial Assignment 7
NA 4
Sequential Assignment 2

Primary Purpose

primary_purpose Study_Count
Treatment 565
NA 36
Basic Science 28
Prevention 21
Diagnostic 17
Other 15
Supportive Care 5
Screening 4
Health Services Research 2

Observational Studies

Studies by Country

Country Study_Count
NA 23
United States 15
Germany 11
France 6
Italy 5
United Kingdom 5
Korea, Republic of 4
Canada 3
Belgium 2
Israel 2
Poland 2
Spain 2
Thailand 2
Austria 1
China 1
Denmark 1
Hong Kong 1
Hungary 1
Indonesia|Singapore 1
Japan 1
Lithuania 1
Mexico 1
Norway 1
Portugal 1
Singapore 1
Switzerland 1
Turkey 1

Sites per Study

Site_count Study_Count
1 86
2 3
3 1
4 1
5 1
6 1
9 1
10 1
15 1

Enrollment Metrics

Measure Observational
Min 1.000
1st Qu 55.000
Median 150.000
Mean 2099.579
3rd Qu 733.500
Max 100000.000

Observation Model

observational_model Study_Count
Cohort 37
NA 15
Case-Only 12
Case-Control 10
Other 9
Case Control 7
Ecologic or Community 5
Natural History 1

Time Perspective

time_perspective Study_Count
Prospective 60
Cross-Sectional 13
Retrospective 10
NA 7
Other 3
Cross-Sectional, Prospective 2
Longitudinal, Prospective 1

Registries

Studies by Country

Country Study_Count
United States 2
Austria 1
Thailand 1

Sites per Study

Site_count Study_Count
1 2
23 1
46 1

Enrollment Metrics

Measure Registries
Min 32
1st Qu 233
Median 400
Mean 414
3rd Qu 581
Max 824

Registry Model

observational_model Study_Count
Cohort 3
Other 1

Time Perspective

time_perspective Study_Count
Prospective 4

Follow-up

target_duration Study_Count
6 Months 2
2 Years 1
24 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03363698 MCT and Capsaicin Provocation Challenge in Diagnosis of Chronic Cough https://ClinicalTrials.gov/show/NCT03363698 Recruiting Medical University of Warsaw 2021-09-30
NCT03324100 Integrative Omics Approach to Allergic Rhinitis https://ClinicalTrials.gov/show/NCT03324100 Active, not recruiting Medical University of Graz 2020-03-01
NCT03286049 Short and Mid-term Repeatability of Active Anterior Rhinomanometry (AAR) Measurements in Paediatric Age https://ClinicalTrials.gov/show/NCT03286049 Completed Istituto per la Ricerca e l’Innovazione Biomedica 2018-07-31
NCT03276416 RAPP-children, Rhinitis & Asthma in Patient Perspective: Development and Validation of a Questionnaire for Quality of Life Evaluation in Children With Asthma and Allergic Rhinitis https://ClinicalTrials.gov/show/NCT03276416 Completed Istituto per la Ricerca e l’Innovazione Biomedica 2019-07-31
NCT03251157 Dietary Intake in Adults From the GA2LEN Folow-up Survey https://ClinicalTrials.gov/show/NCT03251157 Completed Johns Hopkins Bloomberg School of Public Health 2010-12-31
NCT03112252 App Based Study on the Symptoms of Patients With Allergic Rhinitis in the Pollen Season https://ClinicalTrials.gov/show/NCT03112252 Completed University Hospital of Cologne 2017-08-31
NCT03101618 Animal Allergy in Korean Pet Owners, Pet-related Industry Workers, and Laboratory Animal Reseachers https://ClinicalTrials.gov/show/NCT03101618 Completed Gachon University Gil Medical Center 2016-11-27
NCT03097432 Non-interventional Study to Assess the Tolerability, the Safety Profile and the Adherence of Different Up-dosing Schemes for a Sublingual Immunotherapy Treatment https://ClinicalTrials.gov/show/NCT03097432 Completed University Hospital of Cologne 2017-10-19
NCT03070288 RGB(Red- Green-Blue) Measurement of the Nasal Mucosal Image https://ClinicalTrials.gov/show/NCT03070288 Completed Bezmialem Vakif University 2018-03-01
NCT03014661 Untersuchung Zur Erfassung Und Kontrolle Der Lebensqualität Unter Einer Therapie Mit Pollinex Quattro Bei Heuschnupfen https://ClinicalTrials.gov/show/NCT03014661 Completed Saarland University 2015-12-31
NCT02879929 Development and Validity of the DyNaChron Questionnaire for Chronic Nasal Dysfunction https://ClinicalTrials.gov/show/NCT02879929 Completed Central Hospital, Nancy, France 2006-12-31
NCT02866864 Animal Allergy in Korean Veterinary Researcher https://ClinicalTrials.gov/show/NCT02866864 Completed Gachon University Gil Medical Center 2016-08-26
NCT02856282 Drug Utilization Study for Pirinase Hayfever Relief https://ClinicalTrials.gov/show/NCT02856282 Completed GlaxoSmithKline 2018-03-31
NCT02745418 The Role of Filaggrin Mutations and Sensitization Pathways in Allergic Rhinitis and Peanut Allergy https://ClinicalTrials.gov/show/NCT02745418 Recruiting Queen’s University 2019-08-31
NCT02636933 Longitudinal Observational Study in Prematurely Born Preschool Children: Assessment of Lung Function Parameters https://ClinicalTrials.gov/show/NCT02636933 Recruiting Istituto per la Ricerca e l’Innovazione Biomedica 2020-12-31
NCT02609581 Tolerability of SLIT With LAIS® Mites Allergoid Tablets https://ClinicalTrials.gov/show/NCT02609581 Completed University Hospital of Cologne 2017-02-28
NCT02409550 CARATKids: Italian Validation of Asthma and Allergic Rhinitis Control Test in Children https://ClinicalTrials.gov/show/NCT02409550 Completed Istituto per la Ricerca e l’Innovazione Biomedica 2016-07-31
NCT02380495 “Studio NaVA” - National Study on Quality of Life in Adolescents Affected by Allergic Rhinitis With or Without Asthma https://ClinicalTrials.gov/show/NCT02380495 Completed Istituto per la Ricerca e l’Innovazione Biomedica 2017-03-31
NCT02360072 Airway Inflammation and Bronchial Hyperresponsiveness in Rhinitic Children With or Without Asthma https://ClinicalTrials.gov/show/NCT02360072 Completed Guangzhou Institute of Respiratory Disease 2015-09-30
NCT02295969 Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis https://ClinicalTrials.gov/show/NCT02295969 Completed Stallergenes Greer 2017-07-03
NCT02279706 Korean Linguistic Adaptation of Rhinitis Controlled Assessment Test https://ClinicalTrials.gov/show/NCT02279706 Completed Ajou University School of Medicine 2015-09-30
NCT02238236 Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermatitis, Urticaria and Pruritus https://ClinicalTrials.gov/show/NCT02238236 Completed Boehringer Ingelheim 2008-04-30
NCT02238223 Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® Tablet https://ClinicalTrials.gov/show/NCT02238223 Completed Boehringer Ingelheim 2006-05-31
NCT02230475 Systemic Mechanisms in Allergic Rhinitis: Assessment of Metabolomic Outcomes. https://ClinicalTrials.gov/show/NCT02230475 Completed Queen’s University 2014-09-30
NCT01318954 The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis https://ClinicalTrials.gov/show/NCT01318954 Completed Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C. 2011-06-30
NCT02133053 Application of Ectoin Allergy Nasal Spray in Comparison to Beclomethasone Nasal Spray https://ClinicalTrials.gov/show/NCT02133053 Completed Bitop AG 2011-07-31
NCT02131051 Application of Ectoine Containing Nasal Spray and Eye Drops in Patients With Allergic Rhinitis https://ClinicalTrials.gov/show/NCT02131051 Completed Bitop AG 2010-09-30
NCT02131038 Application of Ectoine Nasal Spray in Comparison With Cromolyn Sodium Containing Nasal Spray in Patients With Allergic Rhinitis https://ClinicalTrials.gov/show/NCT02131038 Completed Bitop AG 2009-09-30
NCT01295866 Evaluation Effects of Nasal Nitric Oxide Measurements Are Associated With Atopy Status in Chronic Nasal Inflammation https://ClinicalTrials.gov/show/NCT01295866 Completed Beijing Tongren Hospital 2010-10-31
NCT01295255 Interaction Effect of Asthma and Aeroallergen Category on the Psychological Status in Allergic Rhinitis Patients https://ClinicalTrials.gov/show/NCT01295255 Completed Beijing Tongren Hospital 2009-10-31
NCT02020902 Post Marketing Surveillance for Contac Bien Z in Japan https://ClinicalTrials.gov/show/NCT02020902 Completed GlaxoSmithKline 2016-01-31
NCT01971086 Treatment With Rhinospray Plus in Patients With Acute Rhinitis in the Everyday Curative Routine in Hungary https://ClinicalTrials.gov/show/NCT01971086 Completed Boehringer Ingelheim 2014-03-31
NCT01953471 Prospective Observational Study for Determination of Minimal Clinically Important Difference of Allergic Rhinitis Symptoms Due to Grass Pollen (Equinoxe 2) https://ClinicalTrials.gov/show/NCT01953471 Completed Hopital Foch 2011-09-30
NCT01897506 Assessing Risk of Food Insecurity Within Households of Children With Food Allergy https://ClinicalTrials.gov/show/NCT01897506 Completed Arkansas Children’s Hospital Research Institute 2015-12-31
NCT01875276 Evaluating the Need for New Rhinitis Treatment https://ClinicalTrials.gov/show/NCT01875276 Completed Research in Real-Life Ltd 2013-03-31
NCT01854580 Evaluation of an Integrated Care Project https://ClinicalTrials.gov/show/NCT01854580 Completed Charite University, Berlin, Germany 2018-12-31
NCT01845051 Is There a Comorbidity Between Migraine and Allergic Rhinitis? https://ClinicalTrials.gov/show/NCT01845051 Completed Baskent University 2013-03-31
NCT01777438 Evaluating Symptom Control in in Allergic Rhinitis at Three Years After Starting Immunotherapy https://ClinicalTrials.gov/show/NCT01777438 Completed Universitaire Ziekenhuizen Leuven 2013-06-30
NCT01771120 Control and Burden of Asthma and Rhinitis https://ClinicalTrials.gov/show/NCT01771120 Completed Universidade do Porto 2014-07-31
NCT01686048 The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel https://ClinicalTrials.gov/show/NCT01686048 Completed Meir Medical Center 2015-04-30
NCT01686022 Grass Sensitisation and Allergic Rhinitis in Thai Patients https://ClinicalTrials.gov/show/NCT01686022 Completed Mahidol University 2015-10-31
NCT01684540 Application of Ectoin® Rhinitis Nasal Spray in Patients With Acute Rhinosinusitis https://ClinicalTrials.gov/show/NCT01684540 Completed Bitop AG 2012-08-31
NCT01602237 Preventing Respiratory Health Problems in Bakery Employees https://ClinicalTrials.gov/show/NCT01602237 Completed Haukeland University Hospital 2012-12-31
NCT01553110 An Observational Study to Evaluate The Relationship of Nasal Mucus Properties and Symptoms https://ClinicalTrials.gov/show/NCT01553110 Completed Virginia Commonwealth University 2018-12-31
NCT01549340 Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy (MK-7243-022) https://ClinicalTrials.gov/show/NCT01549340 Completed ALK-Abelló A/S 2012-05-31
NCT01489293 Inhibitory Receptors in Eosinophils of Atopic Subjects https://ClinicalTrials.gov/show/NCT01489293 Completed Meir Medical Center 2013-12-31
NCT01461200 Effects of Allergic Rhinitis on the Nasal/Sinus Microbiome https://ClinicalTrials.gov/show/NCT01461200 Completed University of Chicago 2012-01-31
NCT01445262 Drug Use Investigation for XYZAL® https://ClinicalTrials.gov/show/NCT01445262 Completed GlaxoSmithKline 2013-12-31
NCT01420822 Special Drug Use Investigation for ALLERMIST (Long Term) https://ClinicalTrials.gov/show/NCT01420822 Completed GlaxoSmithKline 2014-08-31
NCT01383941 Asthma Phenotypes in the Inner City https://ClinicalTrials.gov/show/NCT01383941 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2014-09-30
NCT01376206 Drug Use Investigation for ALLERMIST https://ClinicalTrials.gov/show/NCT01376206 Completed GlaxoSmithKline 2010-09-30
NCT01369563 Efficacy, Safety & Tolerability of Ciclesonide 200mcg Spray 4 Weeks Treatment for Intermittent & Persistent Rhinitis https://ClinicalTrials.gov/show/NCT01369563 Completed AstraZeneca 2012-05-31
NCT04389034 Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglobulin E (IgE) Levels https://ClinicalTrials.gov/show/NCT04389034 Recruiting Allergy Therapeutics 2020-10-31
NCT04125888 Impact of AIT on Allergic Rhinitis and Asthma https://ClinicalTrials.gov/show/NCT04125888 Active, not recruiting ALK-Abelló A/S 2020-12-31
NCT04104828 Comparison of Innate Immune Responses Induced by Allergy Immunotherapy (AIT) With Different Adjuvants https://ClinicalTrials.gov/show/NCT04104828 Recruiting University of Zurich 2020-03-31
NCT04012216 Sleep Respiratory Disorders in Patients With Moderate to Severe Persistent Rhinitis https://ClinicalTrials.gov/show/NCT04012216 Recruiting University Hospital, Montpellier 2021-01-31
NCT03893227 Prevalence of Nasal Hyperreactivity in Chronic Upper Airway Inflammation https://ClinicalTrials.gov/show/NCT03893227 Recruiting Universitaire Ziekenhuizen Leuven 2020-06-30
NCT03746860 N.I.S of AIT in Adult Patients With House Dust Mite Allergy in Real Practice in France https://ClinicalTrials.gov/show/NCT03746860 Recruiting ALK-Abelló A/S 2020-05-31
NCT03714945 Study on Association Between Treatment of Allergic Rhinitis and Cognitive Ability in Children https://ClinicalTrials.gov/show/NCT03714945 Recruiting Chinese University of Hong Kong 2020-12-31
NCT03599908 Evaluation and Validation of Novel Diagnostic Tool for Allergists (AbioSCOPE) https://ClinicalTrials.gov/show/NCT03599908 Completed Centre Hospitalier Universitaire Vaudois 2016-11-14
NCT01199757 A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures https://ClinicalTrials.gov/show/NCT01199757 Completed GlaxoSmithKline 2009-08-01
NCT01192386 Eosinophil Markers and Development of Disease in Allergic Rhinitis https://ClinicalTrials.gov/show/NCT01192386 Completed University of Aarhus 2010-05-31
NCT01129765 Home Usability of a Nasal Lavage System in Children https://ClinicalTrials.gov/show/NCT01129765 Completed Aardvark Medical Company 2009-08-31
NCT01113697 Genetics of the Early and Late Response to Allergen Challenge https://ClinicalTrials.gov/show/NCT01113697 Recruiting University of British Columbia 2020-12-31
NCT01104012 Validation of Proteomic Analyses for Allergic Asthma and Rhinitis https://ClinicalTrials.gov/show/NCT01104012 Completed Centre Hospitalier Universitaire de NÄ«mes 2012-10-31
NCT01077609 Flixonase Safety in Patients With Allergic Rhinitis (AR) https://ClinicalTrials.gov/show/NCT01077609 Completed GlaxoSmithKline 2010-04-30
NCT01068808 The Development of Allergic Rhinitis in Children Previously Diagnosed as Nonallergic Rhinitis https://ClinicalTrials.gov/show/NCT01068808 Completed Mahidol University 2012-06-30
NCT01001130 Regulatory AVAMYS Nasal Spray PMS https://ClinicalTrials.gov/show/NCT01001130 Completed GlaxoSmithKline 2014-05-31
NCT00903721 Nasonex® Nasal Suspension 50 μg Long-term Designated Drug Use Investigation (Study P05876) https://ClinicalTrials.gov/show/NCT00903721 Completed Merck Sharp & Dohme Corp. 2012-10-31
NCT00831428 Screening Scottish Swimmers for Asthma and Rhinitis https://ClinicalTrials.gov/show/NCT00831428 Completed University of Dundee 2009-05-31
NCT00826189 Influence of Probiotics on Atopy With Focus on Respiratory Allergic Diseases- Follow-up to 7 Years https://ClinicalTrials.gov/show/NCT00826189 Completed National University Hospital, Singapore 2013-06-30
NCT00815984 Fractional Exhaled Nitric Oxide (FeNO) Result Prediction Factors in Children With Allergic Diseases https://ClinicalTrials.gov/show/NCT00815984 Completed Medical Universtity of Lodz 2010-01-31
NCT01936818 Study Evaluating Nasal Symptoms Induced by a Nasal Allergen Challenge (NAC) To House Dust Mite Allergen https://ClinicalTrials.gov/show/NCT01936818 Completed ORA, Inc. 2015-01-31
NCT01699659 The Efficacy & Safety of the UAS Immunotherapy Protocol https://ClinicalTrials.gov/show/NCT01699659 Completed United Allergy Services 2012-09-30
NCT01485523 Sensitivity and Specificity of Nasal Provocation Test in Allergic Rhinitis to House Dust Mites https://ClinicalTrials.gov/show/NCT01485523 Completed University Hospital, Strasbourg, France 2012-08-31
NCT03821077 Study to Evaluate the Efficacy and Safety of “Allergovac Poliplus” in Polysensitized Patients With Allergic Rhinitis/Rhinoconjunctivitis, With or Without Asthma https://ClinicalTrials.gov/show/NCT03821077 Active, not recruiting Roxall Medicina España S.A 2021-06-30
NCT04132258 “Clinical and Epidemiological Characteristics of Inflammatory Rhinitis in Patients on Biotherapies” https://ClinicalTrials.gov/show/NCT04132258 Recruiting Nantes University Hospital 2020-11-01
NCT02844842 Evaluation of Tolerability and Safety of “Allergovac Poliplus” in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice https://ClinicalTrials.gov/show/NCT02844842 Completed Roxall Medicina España S.A 2018-09-06
NCT02579720 Revaccination With Pollinex® Quattro https://ClinicalTrials.gov/show/NCT02579720 Completed University Hospital of Cologne 2015-10-31
NCT02553590 Tolerability of SLIT With LAIS® 2-Tree Allergoid Tablets https://ClinicalTrials.gov/show/NCT02553590 Completed University Hospital of Cologne 2015-10-31
NCT04352088 Immune Response Features in Allergic Airway Diseases https://ClinicalTrials.gov/show/NCT04352088 Recruiting Lithuanian University of Health Sciences 2022-11-30
NCT00762983 Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED) https://ClinicalTrials.gov/show/NCT00762983 Completed Merck Sharp & Dohme Corp. 2009-02-28
NCT00761527 Observation of Side Effects and Effectiveness of Desloratadine (Aerius) Syrup in Filipino Children (Study P05634) https://ClinicalTrials.gov/show/NCT00761527 Completed Merck Sharp & Dohme Corp. 2010-05-31
NCT00724698 Evaluation of Desloratadine When Used in Patients With Either Allergic Rhinitis or Chronic Idiopathic Urticaria https://ClinicalTrials.gov/show/NCT00724698 Completed Merck Sharp & Dohme Corp. 2007-12-31
NCT00723736 Safety of Aerius Syrup in Pediatric Patients Aged 1-5 Years Old With Allergic Rhinitis or Chronic Idiopathic Urticaria (Study P04446AM1)(COMPLETED) https://ClinicalTrials.gov/show/NCT00723736 Completed Merck Sharp & Dohme Corp. 2008-06-30
NCT00713089 Study of Stool Microbiota in Two Diverse Cohorts of Asian and Its Influence on Allergy Development https://ClinicalTrials.gov/show/NCT00713089 Completed National University Hospital, Singapore 2009-11-30
NCT00704769 Response of Desloratadine Syrup in the Relief of Symptoms Associated With Perennial Allergic Rhinitis in Pediatric Patients (Study P04299) https://ClinicalTrials.gov/show/NCT00704769 Completed Merck Sharp & Dohme Corp. 2007-12-31
NCT00598780 Evaluation of Safety of Levocetirizine in Routine Clinical Practice-non- Interventional Study https://ClinicalTrials.gov/show/NCT00598780 Completed UCB Pharma 2008-09-30
NCT00517946 A Study To Investigate If MRI Scanning Is Effective At Seeing What Hayfever Drugs Do In Nasal Passage. https://ClinicalTrials.gov/show/NCT00517946 Completed GlaxoSmithKline 2007-04-30
NCT00438646 Oral Bacteria and Allergic Disease in Children https://ClinicalTrials.gov/show/NCT00438646 Completed National Institutes of Health Clinical Center (CC) 2008-12-31
NCT00427479 Oral Allergy Syndrome (OAS): a Pilot Study to Evaluate a Clinical Questionnaire as a Diagnostic Tool https://ClinicalTrials.gov/show/NCT00427479 Completed Royal Brompton & Harefield NHS Foundation Trust NA
NCT00405899 Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections https://ClinicalTrials.gov/show/NCT00405899 Completed West Penn Allegheny Health System NA
NCT00355160 Non-Rhinologic Etiologies of Headaches and Facial Pain in Tertiary Care Setting https://ClinicalTrials.gov/show/NCT00355160 Completed Penn State University 2009-04-30
NCT00297843 A Pilot Monocenter Study to Assess Cellular and Soluble Biomarkers in Nasal Secretions https://ClinicalTrials.gov/show/NCT00297843 Completed Fraunhofer-Institute of Toxicology and Experimental Medicine NA
NCT00189449 Effects of Long-Term Treatment With Nasally Inhaled Triamcinolone Acetonide in Children With Allergic Rhinitis https://ClinicalTrials.gov/show/NCT00189449 Completed West Penn Allegheny Health System NA
NCT00011440 Pollutant Altered Allergic Responses https://ClinicalTrials.gov/show/NCT00011440 Completed National Institute of Environmental Health Sciences (NIEHS) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03127436 Non-interventional Study to Assess the Tolerability and the Safety Profile of SCIT Therapy With Acarovac® Hausstaubmilbe https://ClinicalTrials.gov/show/NCT03127436 Completed University Hospital of Cologne 2019-02-14
NCT02000648 Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in Thailand https://ClinicalTrials.gov/show/NCT02000648 Completed Chulalongkorn University 2015-02-28
NCT01632540 Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT01632540 Completed Teva Pharmaceutical Industries 2013-12-31
NCT03739216 Registry of Subject Treated With ClariFix https://ClinicalTrials.gov/show/NCT03739216 Active, not recruiting Arrinex, Inc. 2021-06-30